InvestorsHub Logo
Followers 11
Posts 1184
Boards Moderated 0
Alias Born 05/03/2004

Re: None

Tuesday, 12/24/2019 5:06:51 PM

Tuesday, December 24, 2019 5:06:51 PM

Post# of 226
"We have acquired vested pharmaceutical R&D licenses as well as Active Ingredient licenses, and a comprehensive IP portfolio that includes over 150 patents," said CEO Kashif Shan. "This acquisition helps speed along our pharmaceutical division and Rx joint ventures in the active ingredient and new product development space," said Shan.

https://www.prnewswire.com/news-releases/folium-biosciences-acquires-amsterdams-leading-cannabinoid-extraction--technology-company-300807785.html

"The 19th century belonged to England, the 20th century belonged to the U.S., and the 21st century belongs to China. Invest accordingly." -- Warren Buffett